Manchester, New Hampshire-based Sequel currently offers twiist for type 1 diabetes, launching earlier this year. It shared ...

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

Sequel Med Tech, LLC, today announced results from a multi-center pivotal trial evaluating the safety and efficacy of the investigational twiist™ Automated Insulin Delivery (AID) System in adults with ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can help users better manage their type 2 diabetes by recommending insulin-dose ...

In adults with insulin-treated type 2 diabetes, an automated insulin delivery system conferred lower HbA1c and improved time ...

ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen ...